Your browser doesn't support javascript.
loading
Integrin ß4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1.
Fang, Huan; Ren, Wenlong; Cui, Qiuxia; Liang, Huichun; Yang, Chuanyu; Liu, Wenjing; Wang, Xinye; Liu, Xue; Shi, Yujie; Feng, Jing; Chen, Ceshi.
Afiliação
  • Fang H; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
  • Ren W; Kunming College of Life Sciences, University of Chinese Academy of Sciences, Kunming, Yunnan, China.
  • Cui Q; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
  • Liang H; School of Life Science, University of Science & Technology of China, Hefei, China.
  • Yang C; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
  • Liu W; Affiliated Hospital of Guangdong Medical University, Guangdong, China.
  • Wang X; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
  • Liu X; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
  • Shi Y; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
  • Feng J; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
  • Chen C; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
Elife ; 122023 10 03.
Article em En | MEDLINE | ID: mdl-37787041

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China